Pfizer recalls blood pressure drug Accuretic due to potential carcinogen MD Bureau22 March 2022 5:26 PM ISTPfizer said it has not received any reports of adverse events related to the drug till date.
Granules India Receives Licences from MPP to Market generic of Pfizers Paxlovid MD Bureau21 March 2022 11:46 AM ISTThe product will be made at Granules manufacturing facilities in India that are approved by global regulatory agencies including USFDA. The license...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
Pfizer, Bayer to maintain essential drug supply to Russia MD Bureau16 March 2022 3:44 PM ISTPfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential...
Pfizer, GITAM University launch a BSc Chemistry Course Medical Dialogues Bureau8 March 2022 4:53 PM ISTNew Delhi: One of the world's premier biopharmaceutical companies Pfizer Healthcare in association with GITAM Deemed to be University, has launched an...
Pfizer Canada recalls BP drug on potential cancer-causing impurity MD Bureau7 March 2022 11:49 AM ISTPatients can continue to take their medication as prescribed and do not need to return the drug to their pharmacy, the agency said, but asked patients...
PFIZER Clostridium difficile Vaccine did not meet primary endpoints: PHASE 3 CLOVER Trial MD Bureau6 March 2022 1:29 PM ISTNew York: Pfizer Inc. announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating its...
Pfizer's bacteria prevention vaccine fails at main stage MD Bureau5 March 2022 1:27 PM ISTThe infection is associated with diarrhea that may progress to a severe and debilitating illness and even result in death.
Study: Pfizer-BioNTech Covid vaccine less effective in kids MD Bureau3 March 2022 2:07 PM ISTThe study, led by The New York State Department of Health, found that during the Omicron era, the effectiveness of the Pfizer-BioNTech Covid vaccine...
Pfizer supplemental application for ABRILADA interchangeability accepted by USFDA for review MD Bureau27 Feb 2022 10:30 AM ISTNew Delhi: Pfizer Inc. has announced that the U.S. Food and Drug Administration (USFDA) has accepted for review the Prior Approval Supplement (PAS) to...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Pfizer COVID vaccine approved in South Korea for 5-11 years old MD Bureau24 Feb 2022 10:00 AM ISTThe vaccine will help protect younger children from infections or serious illness amid South Korea's fast-developing omicron surge, the MDFS added.
